A Comprehensive Development Resource for the Life Sciences Industry

The Life Sciences Development Group specializes in facilities development across a broad range of companies and locations. Over the past seven years, LSDG firms have completed projects for over 70 different clients and 14 million square feet costing over $3 billion.

The Group portfolio includes clients in major pharmaceutical as well as early and later-stage biotech companies such as Pfizer, Amgen, Becton Dickinson, Guidant, Scripps, Zyomyx, Raven, Cytokinetics, Exelixis, Rigel, Aradigm, Sequenom, Nellcor, Syrrx, Fibrogen, Skyepharma and the La Jolla Institute for Allergy and Immunology. Group firms have completed projects featuring numerous platform technologies and product areas, including therapeutic compounds, informatics, robotics, diagnostic devices, drug delivery technologies and analytical tools.

LSDG has extensive experience in complex life sciences projects, including state-of-the-art research buildings incorporating clean rooms, NMRI rooms, chemistry and biology labs, cold rooms, autoclaves, pilot plant facilities and the sophisticated mechanical, electrical and plumbing systems required to support the science and the operations.

The Group works cooperatively with its clients on all aspects of building programming, design, construction and leasing to create facilities that are efficient and economic.